These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1794415

  • 1. Ridogrel prevents the thromboxane-mediated pressor response and oedema induced by hydrogen peroxide in isolated rabbit lungs.
    Corten I, Peeters FA, Rampart M, Bult H, Buyssens N, Herman AG.
    Eur J Pharmacol; 1991 Aug 16; 201(1):83-90. PubMed ID: 1794415
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb 16; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 3. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
    Quest DW, Wilson TW.
    Jpn J Pharmacol; 1998 Dec 16; 78(4):479-86. PubMed ID: 9920205
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G, Hemans C, Van de Water A, Xhonneux R, Wouters L, Van Ammel K, De Clerck F.
    Circ Res; 1991 Aug 16; 69(2):313-24. PubMed ID: 1830517
    [Abstract] [Full Text] [Related]

  • 5. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C, Beetens JR, Tegtmeier F, Van Rooy P, Vercammen E, Wouters L, De Clerck F.
    Thromb Haemost; 1992 Aug 03; 68(2):214-20. PubMed ID: 1412169
    [Abstract] [Full Text] [Related]

  • 6. C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.
    Morganroth ML, Schoeneich SO, Till GO, Ward PA, Horvath SJ, Glovsky MM.
    Am Rev Respir Dis; 1990 Feb 03; 141(2):296-300. PubMed ID: 2105683
    [Abstract] [Full Text] [Related]

  • 7. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
    De Clerck F, Loots W, Somers Y, Beetens J, Wouters L, Wynants J, Janssen PA.
    Br J Pharmacol; 1990 Apr 03; 99(4):631-6. PubMed ID: 2113823
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury.
    Ljungman AG, Grum CM, Deeb GM, Bolling SF, Morganroth ML.
    Am Rev Respir Dis; 1991 Mar 03; 143(3):610-7. PubMed ID: 1900402
    [Abstract] [Full Text] [Related]

  • 9. Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.
    Janssens WJ, Cools FJ, Hoskens LA, Van Nueten JM.
    Thromb Haemost; 1990 Aug 13; 64(1):91-6. PubMed ID: 2148850
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury.
    Zamora CA, Baron DA, Heffner JE.
    J Appl Physiol (1985); 1993 Jan 13; 74(1):224-9. PubMed ID: 8444695
    [Abstract] [Full Text] [Related]

  • 12. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis.
    Vanden Bossche H, Willemsens G, Bellens D, Janssen PA.
    Biochem Pharmacol; 1992 Feb 18; 43(4):739-44. PubMed ID: 1540227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.
    Ritter JM, Barrow SE, Doktor HS, Stratton PD, Edwards JS, Henry JA, Gould S.
    Hypertension; 1993 Aug 18; 22(2):197-203. PubMed ID: 8340155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
    Park SJ, Lee JJ, Vanhoutte PM.
    Zhongguo Yao Li Xue Bao; 1999 Oct 18; 20(10):872-8. PubMed ID: 11270983
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase inhibitor prevents pulmonary edema in response to H2O2.
    Johnson A, Phillips P, Hocking D, Tsan MF, Ferro T.
    Am J Physiol; 1989 Apr 18; 256(4 Pt 2):H1012-22. PubMed ID: 2705544
    [Abstract] [Full Text] [Related]

  • 18. Placental transfer of the thromboxane synthetase inhibitor ridogrel in the late-pregnant ewe.
    Schneider TJ, Struijk PC, Wallenburg HC.
    Eur J Obstet Gynecol Reprod Biol; 1999 Sep 18; 86(1):83-7. PubMed ID: 10471147
    [Abstract] [Full Text] [Related]

  • 19. Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung.
    Bult H, Heiremans JJ, Herman AG, Malcorps CM, Peeters FA.
    Br J Pharmacol; 1988 Apr 18; 93(4):791-802. PubMed ID: 3291998
    [Abstract] [Full Text] [Related]

  • 20. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D, De Clerck F.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.